815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ormat completed a $1 billion offering of convertible senior notes due March 15, 2031 on March 20, 2026, including $825 million of 1.50% Series A notes and $175 million of 0.00% Series B notes. The company used about $287.9 million of proceeds plus about $25 million of cash on hand to repurchase $285.9 million of its 2.50% convertible notes due 2027, and it plans a separate share repurchase of up to $25 million, which it says is intended to offset dilution from the 2027 notes.
Offering totals $1 billion: $825 million of 1.50% Series A notes and $175 million of 0.00% Series B notes, both due 2031, including full exercise of initial purchasers' options.
Initial conversion price is about $140.40 per share, a premium of about 30% over the last reported sale price on March 17, 2026.
Estimated net proceeds are $975.7 million; about $287.9 million and $25 million cash on hand were used to repurchase $285.9 million of 2027 notes.
Series B noteholders may require repurchase at par on March 15, 2027; the company may not redeem either series before March 20, 2029.
On March 16, 2026, Solaris Energy Infrastructure acquired 100% of Focus Genco Cayman Ltd. (Genco) for 4,182,772 Class A common shares and about $81 million in cash, subject to post-closing adjustments. The company also took on a $300 million senior secured term loan and a $148.61 million Stonebriar term loan, and it terminated its Bank of America asset-based lending facility, so shareholders face new share issuance and higher secured debt.
Acquired all outstanding Genco shares on March 16, 2026, for 4,182,772 Class A common shares plus about $81 million in cash.
Sellers have a 90-day lockup on the shares received, and the company agreed to register those shares for resale.
Entered a $300 million senior secured term loan with Goldman Sachs Bank USA, maturing March 15, 2027, at Term SOFR plus 3.00%.
Stonebriar Commercial Finance provided a $148.61 million term loan maturing April 1, 2032, guaranteed by OpCo; the bank facility with Bank of America was terminated with no outstanding borrowings.
The U.S. Attorney's Office for the Southern District of New York unsealed an indictment of three individuals associated with Super Micro Computer over an alleged conspiracy to commit export-control violations. The company is not named as a defendant and says it is cooperating fully with the government's investigation. One of the charged individuals, board member and Senior Vice President of Business Development Yih-Shyan "Wally" Liaw, resigned from the board effective March 20, 2026.
Indictment of three individuals announced March 19, 2026; Super Micro is not named as a defendant
Yih-Shyan "Wally" Liaw resigned from the Board of Directors effective March 20, 2026, not due to a disagreement with the company
Two employees placed on administrative leave and the contractor relationship terminated, effective immediately
DeAnna Luna appointed acting Chief Compliance Officer; the board now has eight directors
Goodyear approved a rationalization plan in Europe, Middle East and Africa on March 16, 2026, to streamline its sales and distribution model. The plan would reduce about 600 positions, add about 200 new roles, and result in a net reduction of about 400 positions, with some portions still subject to employee consultation in certain countries.
Pre-tax charges expected between $100 million and $110 million, including $75 million to $85 million in rationalization charges
Total cash outflows expected at $100 million to $110 million, with $25 million in 2026 and $50 million in 2027
Expected to improve EMEA segment operating income by $35 million to $40 million in 2028 and about $50 million annually thereafter
TG Therapeutics entered a first amendment to its financing agreement on March 18, 2026, establishing a $750 million term loan maturing March 18, 2031, fully borrowed at closing, with part of the proceeds used to repay the existing Initial Term Loans in full. The filing also sets up an uncommitted additional facility of up to $250 million, and the loan is secured by substantially all assets of the company and its guarantor subsidiaries.
$750 million 2026 Term Loan borrowed in full on March 18, 2026, with proceeds partly used to repay Initial Term Loans
Loan matures March 18, 2031; quarterly amortization of $37.5 million begins with the quarter ending March 31, 2030
Pricing grid starts at 4.75% for SOFR borrowings and 3.75% for base rate borrowings, with a 25 basis point step-down tied to leverage
Uncommitted additional facility of up to $250 million; Blue Owl Capital Corporation is administrative agent
Natural Alternatives International's CEO, Mark A. LeDoux, will have his U.S. base salary reduced from $475,000 to $255,000 per year, effective May 1, 2026, as part of an amended employment agreement. He is also taking on the role of Managing Director of the company's Swiss subsidiary under a separate agreement, with a base salary of 170,000 Swiss francs per year, and has committed to spend at least half his time in Switzerland.
U.S. base salary reduced from $475,000 to $255,000 per year, effective May 1, 2026
Certain other company benefits otherwise paid to all officers are also reduced
Separate Swiss employment agreement sets base salary at 170,000 Swiss francs per year, effective May 1, 2026
Company states combined U.S. and Swiss compensation is intended to be approximately the same, subject to currency variations
Ecolab agreed to acquire CoolIT Systems, a maker of liquid cooling systems for AI data centers, for about $4.75 billion in cash, funded with new transaction debt and expected to close in the third quarter of 2026. The company said the deal is expected to add 1% to Ecolab's total organic sales growth rate and to be accretive to adjusted diluted EPS in 2028, while leverage rises to about 3x at closing. Ecolab also set first-quarter 2026 adjusted EPS guidance of $1.69 to $1.71 and kept its full-year 2026 outlook, excluding CoolIT, at $8.43 to $8.63.
Purchase price of approximately $4.75 billion in cash at closing, subject to customary adjustments; 29x and 24x estimated next 12-month and 2027 adjusted EBITDA
Expected to close in the third quarter of 2026, subject to regulatory approvals; financed with new transaction debt, with pro forma net debt to adjusted EBITDA of about 3x at close, returning to 2x by the end of the second year
Q1 2026 adjusted diluted EPS expected at $1.69 to $1.71, up 13% to 14% from $1.50 a year earlier
Full-year 2026 adjusted diluted EPS outlook of $8.43 to $8.63, excluding CoolIT, up 12% to 15% from $7.53 in 2025
On March 19, 2026, Nexstar completed its acquisition of TEGNA under the August 18, 2025 merger agreement, after FCC and DOJ approval. To fund part of the cash consideration, NMI took on new debt, including a bridge facility of up to $2,390 million and term loans totaling $2,900 million, and the company agreed to FCC commitments that include divesting six television stations within two years.
TEGNA shareholders receive $22.00 per share in cash, under the merger agreement signed August 18, 2025
NMI established a bridge facility of up to $2,390 million, maturing on the first anniversary of the closing date
Term loans of $150 million (Term A) and $2,750 million (Term B) were drawn, with $200 million of bridge borrowings also used for cash consideration, TEGNA debt repayment and transaction expenses
FCC commitments include divesting six television stations within two years, subject to a waiver condition
On March 19, 2026, Prestige Consumer Healthcare's subsidiary agreed to acquire Breathe Right and other over-the-counter brands from Foundation for $1.045 billion in cash. The company plans to fund the deal with cash on hand and a new term loan, and expects pro-forma bank-defined net leverage of about 4.0x at closing, with a return below 3.0x targeted in fiscal 2028. Closing is expected in the first half of fiscal 2027 and remains subject to closing conditions, including Hart-Scott-Rodino clearance.
Purchase price is $1.045 billion in cash, or about $900 million net of anticipated tax benefits valued at $150 million.
The acquired portfolio generated about $200 million of revenue and $95 million of EBITDA for the twelve months ended December 31, 2025, a price of about 11.0x EBITDA.
Expected pro-forma bank-defined net leverage is about 4.0x at close, with a target of below 3.0x in fiscal 2028.
Either party may terminate if the deal has not closed by July 20, 2026, subject to exceptions.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.